Healthcare Stocks Generating Strong Revenue Growth This Year

Wall St. Watchdog generated a stock screen that looks for 3 consecutive quarters and 3 consecutive years of revenue growth, with a trailing twelve month year-over-year revenue growth of at least 10%, and a P/E ratio less than 20.  It also sets a minimum market capitalization of $250 million.

Following is information on companies in the Healthcare sector that meet these criteria:

  • Endo Pharmaceuticals (NASDAQ:ENDP): This company operates in the Healthcare sector. Its revenue for the most recent fiscal year was $1,716,229,000, which represents a change of 17.48% for the year over year period. The shares recently traded at $41.47, its P/E for the trailing 12 months is 19.38, its net income is $55,787,000, and its market capitalization is $4,833,185,000. About the company:  Endo Pharmaceuticals Holdings Inc. is a specialty pharmaceutical company with products that provide pain management. The Company researches, develops, produces, and markets both branded and generic pharmaceuticals. Endo’s products include Percocet, Percodan, and Lidoderm.
  • AMERIGROUP Corporation (NYSE:AGP): This company operates in the Healthcare sector. Its revenue for the most recent fiscal year was $5,806,301,000, which represents a change of 11.92% for the year over year period. The shares recently traded at $73.90, its P/E for the trailing 12 months is 12.41, its net income is $70,477,000, and its market capitalization is $3,665,663,000. About the company:  AMERIGROUP Corporation, a multi-state managed healthcare company, serves people who receive healthcare benefits through state-sponsored programs. Programs include Medicaid, Children’s Health Insurance Program, and Family Care. The Company provides managed care and medical management programs, as well as offers community-based education and outreach programs.
  • Mednax Inc. (NYSE:MD): This company operates in the Healthcare sector. Its revenue for the most recent fiscal year was $1,401,559,000, which represents a change of 8.79% for the year over year period. The shares recently traded at $73.65, its P/E for the trailing 12 months is 16.78, its net income is $45,456,000, and its market capitalization is $3,544,532,000. About the company:  MEDNAX, Inc., through a subsidiary, provides physician management services to hospital-based neonatal, maternal – fetal, pediatric cardiology, and pediatric intensive care specialties. The Company also manages anesthesia practices.
  • BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): This company operates in the Healthcare sector. Its revenue for the most recent fiscal year was $376,267,000, which represents a change of 15.90% for the year over year period. The shares recently traded at $28.88, its P/E for the trailing 12 months is 18.99, its net income is ($4,371,000), and its market capitalization is $3,203,069,000. About the company:  BioMarin Pharmaceutical Inc. develops and commercializes therapeutic enzyme products. The Company has applied its proprietary enzyme technology to develop products for lysosomal storage diseases and for the treatment of serious burns. BioMarin’s subsidiary provides analytical and diagnostic products and services in the area of carbohydrate biology.
  • Health Management Associates, Inc. (NYSE:HMA): This company operates in the Healthcare sector. Its revenue for the most recent fiscal year was $5,114,997,000, which represents a change of 12.25% for the year over year period. The shares recently traded at $10.96, its P/E for the trailing 12 months is 17.38, its net income is $55,524,000, and its market capitalization is $2,774,769,000. About the company:  Health Management Associates Inc. operates general acute care hospitals in rural communities located primarily in the southeastern and southwestern United States. The Company’s facilities offer a wide range of medical and surgical services.
  • LifePoint Hospitals, Inc. (NASDAQ:LPNT): This company operates in the Healthcare sector. Its revenue for the most recent fiscal year was $3,262,400,000, which represents a change of 10.12% for the year over year period. The shares recently traded at $40.00, its P/E for the trailing 12 months is 13.28, its net income is $46,100,000, and its market capitalization is $2,099,633,000. About the company:  LifePoint Hospitals, Inc. provides health care services through its hospitals. The Company’s facilities are primarily located in non-urban areas where its hospital is the only one in the community. LifePoint’s hospitals are currently located in Alabama, Florida, Georgia, Kansas, Tennessee, Kentucky, Louisiana, Utah, and Wyoming.
  • ViroPharma Incorporated (NASDAQ:VPHM): This company operates in the Healthcare sector. Its revenue for the most recent fiscal year was $439,012,000, which represents a change of 41.41% for the year over year period. The shares recently traded at $19.99, its P/E for the trailing 12 months is 12.39, its net income is $36,446,000, and its market capitalization is $1,518,538,000. About the company:  ViroPharma Incorporated is a biopharmaceutical company committed to the commercialization, development, and discovery of new medicines. The Company’s products include a treatment for prophylaxis of hereditary angioedema as well a capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection and enterocolitis.
  • Select Medical Holdings Corporation (NYSE:SEM): This company operates in the Healthcare sector. Its revenue for the most recent fiscal year was $2,390,290,000, which represents a change of 6.72% for the year over year period. The shares recently traded at $8.92, its P/E for the trailing 12 months is 16.17, its net income is $33,672,000, and its market capitalization is $1,376,116,000. About the company:  Select Medical Holdings Corporation is an operator of specialty hospitals and outpatient rehabilitation clinics. The Company provides medical rehabilitation services on a contract basis at nursing homes, hospitals, assisted living and senior care centers, schools and work sites.
  • WuXi PharmaTech (Cayman) Inc. (NYSE:WX): This company operates in the Healthcare sector. Its revenue for the most recent fiscal year was $334,061,000, which represents a change of 23.72% for the year over year period. The shares recently traded at $16.98, its P/E for the trailing 12 months is 13.56, its net income is $18,224,000, and its market capitalization is $1,201,270,000. About the company:  WuXi PharmaTech (Cayman) Inc. provides pharmaceutical and biotechnology research and development outsourcing. The Company’s services include discovery chemistry, service biology, analytical, pharmaceutical development, and manufacturing.
  • The Ensign Group, Inc. (NASDAQ:ENSG): This company operates in the Healthcare sector. Its revenue for the most recent fiscal year was $649,532,000, which represents a change of 19.84% for the year over year period. The shares recently traded at $31.53, its P/E for the trailing 12 months is 15.28, its net income is $12,746,000, and its market capitalization is $659,074,900. About the company:  Ensign Group, Inc. operates facilities offering nursing and rehabilitative care services in multiple states. The Company provides a broad spectrum of nursing and assisted living services, physical, occupational and speech therapies, and other rehabilitative and healthcare services, for both long-term residents and short-stay rehabilitation patients.

(Note: Selected financial data are sourced from screener.co.  All data are assumed to be accurate.)

Get Actionable Investing Insights: Check Out Wall St. Cheat Sheet’s newest Feature Trades of the Month!

More from The Cheat Sheet